- Home
- GCO vs MREO Comparison
GCO vs MREO Comparison
Compare GCO & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCO
- MREO
- Stock Information
- Founded
- GCO 1924
- MREO 2015
- Country
- GCO United States
- MREO United Kingdom
- Employees
- GCO N/A
- MREO N/A
- Industry
- GCO Clothing/Shoe/Accessory Stores
- MREO Biotechnology: Pharmaceutical Preparations
- Sector
- GCO Consumer Discretionary
- MREO Health Care
- Exchange
- GCO Nasdaq
- MREO Nasdaq
- Market Cap
- GCO 321.1M
- MREO 311.8M
- IPO Year
- GCO N/A
- MREO N/A
- Fundamental
- Price
- GCO $30.69
- MREO $2.07
- Analyst Decision
- GCO Buy
- MREO Strong Buy
- Analyst Count
- GCO 3
- MREO 5
- Target Price
- GCO $32.67
- MREO $7.40
- AVG Volume (30 Days)
- GCO 91.3K
- MREO 1.5M
- Earning Date
- GCO 12-05-2025
- MREO 11-11-2025
- Dividend Yield
- GCO N/A
- MREO N/A
- EPS Growth
- GCO N/A
- MREO N/A
- EPS
- GCO N/A
- MREO N/A
- Revenue
- GCO $2,362,215,000.00
- MREO $500,000.00
- Revenue This Year
- GCO $4.60
- MREO N/A
- Revenue Next Year
- GCO $2.14
- MREO $72.16
- P/E Ratio
- GCO N/A
- MREO N/A
- Revenue Growth
- GCO 2.66
- MREO N/A
- 52 Week Low
- GCO $16.19
- MREO $1.47
- 52 Week High
- GCO $44.80
- MREO $4.42
- Technical
- Relative Strength Index (RSI)
- GCO 55.56
- MREO 55.18
- Support Level
- GCO $28.79
- MREO $1.98
- Resistance Level
- GCO $29.87
- MREO $2.28
- Average True Range (ATR)
- GCO 1.16
- MREO 0.11
- MACD
- GCO 0.23
- MREO -0.01
- Stochastic Oscillator
- GCO 98.70
- MREO 41.83
About GCO Genesco Inc.
Genesco Inc. sells footwear, headwear, sports apparel, and accessories through four main segments. The Journeys Group generates the highest revenue, encompassing the Journeys, Journeys Kidz, and Little Burgundy brands, along with e-commerce and catalog sales. The Schuh Group targets teenagers and young adults aged 16 to 24, focusing on casual and athletic footwear. The Johnston & Murphy Group operates retail shops and factory stores across the United States. Finally, the Genesco Brands Group designs and sources licensed footwear for brands like Levi's, Dockers, and G.H. Bass.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).